UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
_______________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): June 1, 2010
ADVAXIS,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
000-28489
|
02-0563870
|
(Commission
File Number)
|
(IRS
Employer Identification Number)
|
Technology
Centre of New Jersey
675
Rt. 1, Suite B113
North
Brunswick, N.J. 08902
(Address
of principal executive offices)
Registrant’s
telephone number, including area code: (732) 545-1590
Not
applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.07 Submission of Matters to a Vote of Security Holders.
Advaxis,
Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual
Meeting”) on June 1, 2010. The following matters, all of which were set forth in
the Company’s definitive proxy statement on Schedule 14A, as filed with the
Securities and Exchange Commission on April 30, 2010, were voted on at the
Annual Meeting. The final results of such voting are as indicated
below.
|
1.
|
Election
of the five nominees listed below to serve on the Board of Directors of
the Company until the next annual meeting of stockholders or until their
respective successors have been elected and
qualified:
|
Nominee
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
|
|
|
|
Thomas
A. Moore
|
40,244,340
|
N/A
|
1,598,476
|
69,295,653
|
|
|
|
|
|
James
Patton, MD
|
41,213,529
|
N/A
|
629,287
|
69,295,653
|
|
|
|
|
|
Roni
A. Appel
|
39,412,940
|
N/A
|
2,429,876
|
69,295,653
|
|
|
|
|
|
Thomas
McKearn, MD, Ph.D.
|
41,213,529
|
N/A
|
629,287
|
69,295,653
|
|
|
|
|
|
Richard
Berman
|
40,971,529
|
N/A
|
871,287
|
69,295,653
|
|
2.
|
Ratification
and approval of the Company’s Amended and Restated 2009 Stock Option
Plan.
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
|
|
|
38,655,258
|
2,873,437
|
314,121
|
69,295,653
|
|
3.
|
Ratification
of the selection of McGladrey & Pullen, LLP as the Company’s
independent registered public accountants for the fiscal year ending
October 31, 2010.
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
|
|
|
111,080,544
|
21,746
|
36,179
|
0
|
On the
basis of the above votes, (i) all nominees listed above were elected to serve on
the Board of Directors of the Company until the next annual meeting of
stockholders or until their respective successors have been elected and
qualified; (ii) the proposal to ratify and approve the Company’s Amended and
Restated 2009 Stock Option Plan was approved; and (iii) the proposal to ratify
the selection of McGladrey & Pullen, LLP as the Company’s independent
registered public accountants for the fiscal year ending October 31, 2010 was
approved.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: June
3, 2010 |
Advaxis, Inc. |
|
|
|
|
|
|
By:
|
/s/ Mark
J. Rosenblum |
|
|
|
Mark
J. Rosenblum |
|
|
|
Chief
Financial Officer and Secretary |
|
|
|
|
|